Jeil Pharma Holdings Inc (KRX:002620)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,210.00
+70.00 (0.86%)
At close: Feb 20, 2026

Jeil Pharma Holdings Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
126,033120,046180,683236,407245,618325,444
Market Cap Growth
3.66%-33.56%-23.57%-3.75%-24.53%24.71%
Enterprise Value
365,862328,142429,021424,544404,795543,483
Last Close Price
8210.007772.2011624.7615145.0215675.4920687.95
PE Ratio
-----28.47
PS Ratio
0.180.150.230.300.320.43
PB Ratio
0.270.270.450.560.490.65
P/TBV Ratio
0.410.400.670.910.961.39
P/FCF Ratio
-593.17----
P/OCF Ratio
218.3526.43--18.33-
EV/Sales Ratio
0.520.420.530.540.530.71
EV/EBITDA Ratio
7.06112.4612.82126.4648721.6017.73
EV/EBIT Ratio
9.85-20.51--24.70
EV/FCF Ratio
-50.951621.42----
Debt / Equity Ratio
0.360.360.530.390.230.30
Debt / EBITDA Ratio
3.2353.196.4048.4413850.204.89
Debt / FCF Ratio
-766.93----
Net Debt / Equity Ratio
0.200.180.390.260.140.24
Net Debt / EBITDA Ratio
1.8327.194.6332.538166.303.91
Net Debt / FCF Ratio
-13.01391.98-14.57-3.34-6.60-3.58
Asset Turnover
0.810.880.920.900.860.88
Inventory Turnover
3.724.614.945.384.885.17
Quick Ratio
0.760.730.610.650.710.63
Current Ratio
1.151.080.930.981.131.02
Return on Equity (ROE)
-2.38%-15.82%-3.22%-18.07%-2.57%3.05%
Return on Assets (ROA)
2.61%-0.79%1.50%-0.54%-0.63%1.59%
Return on Invested Capital (ROIC)
6.62%-2.08%3.85%-1.38%-1.51%1.79%
Return on Capital Employed (ROCE)
6.70%-2.20%4.50%-1.50%-1.50%3.90%
Earnings Yield
-23.34%-42.62%-8.99%-31.54%-1.42%3.51%
FCF Yield
-5.70%0.17%-5.89%-13.84%-4.19%-10.29%
Dividend Yield
0.61%0.64%0.43%0.33%0.41%0.34%
Payout Ratio
-----13.88%
Buyback Yield / Dilution
0.03%-----
Total Shareholder Return
0.64%0.64%0.43%0.33%0.41%0.34%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.